KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Short-term Investments (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Short-term Investments for 17 consecutive years, with $417.0 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments rose 18.8% to $417.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $417.0 million through Dec 2025, up 18.8% year-over-year, with the annual reading at $417.0 million for FY2025, 18.8% up from the prior year.
  • Short-term Investments hit $417.0 million in Q4 2025 for Abbott Laboratories, up from $222.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $483.0 million in Q1 2022 to a low of $222.0 million in Q3 2025.
  • Historically, Short-term Investments has averaged $337.8 million across 5 years, with a median of $334.5 million in 2023.
  • Biggest five-year swings in Short-term Investments: surged 55.38% in 2021 and later tumbled 36.0% in 2022.
  • Year by year, Short-term Investments stood at $450.0 million in 2021, then crashed by 36.0% to $288.0 million in 2022, then surged by 32.99% to $383.0 million in 2023, then fell by 8.36% to $351.0 million in 2024, then grew by 18.8% to $417.0 million in 2025.
  • Business Quant data shows Short-term Investments for ABT at $417.0 million in Q4 2025, $222.0 million in Q3 2025, and $331.0 million in Q2 2025.